TY - JOUR
T1 - Obesity and its management in primary care setting
AU - Ibrahim, Mahmoud
AU - Ba-Essa, Ebtesam M.
AU - Alvarez, Jessica A.
AU - Baker, Jason
AU - Bruni, Vincenzo
AU - Cahn, Avivit
AU - Ceriello, Antonio
AU - Cosentino, Francesco
AU - Davies, Melanie J.
AU - De Domenico, Francesco
AU - Eckel, Robert H.
AU - Friedman, Allon N.
AU - Goldney, Jonathan
AU - Hamtzany, Omer
AU - Isaacs, Scott
AU - Karadeniz, Sehnaz
AU - Leslie, Richard David
AU - Lingvay, Ildiko
AU - McLaughlin, Sue
AU - Mobarak, Omar
AU - Del Prato, Stefano
AU - Prattichizzo, Francesco
AU - Rizzo, Manfredi
AU - Rötzer, René D.
AU - le Roux, Carel W.
AU - Schnell, Oliver
AU - Seferovic, Petar M.
AU - Somers, Virend K.
AU - Standl, Eberhard
AU - Thomas, Abraham
AU - Tuccinardi, Dario
AU - Valensi, Paul
AU - Umpierrez, Guillermo E.
N1 - Publisher Copyright:
© 2025
PY - 2025/7
Y1 - 2025/7
N2 - Obesity is a worldwide epidemic affecting adults and children, regardless of their socioeconomic status. Significant progress has been made in understanding the genetic causes contributing to obesity, shedding light on a portion of cases worldwide. In young children with severe obesity however, recessive mutations, i.e., leptin or leptin receptor deficiency should be sought. Much more has been learned about the far-reaching impact of obesity on complications, including cardiovascular disease, liver and kidney dysfunction, diabetes, inflammation, hypertension, sleep, cancer, and the eye. Preventive strategies, particularly in children, are crucial for reducing obesity rates and mitigating its long-term complications. While dietary modifications and lifestyle changes remain the cornerstone of obesity prevention or treatment, recent advancements have introduced highly effective pharmacological options complementing weight-reduction surgery. Newer medications, like incretin-based therapies including glucagon-like peptide-1 agonists (GLP-1RA), have demonstrated remarkable efficacy in promoting weight loss, offering new insights into margining obesity-related conditions. Primary care providers, whether treating adults or children, play a pivotal role in preventing obesity, initiating treatment, and making onward referrals to specialists to assist in managing obesity and obesity-related complications.
AB - Obesity is a worldwide epidemic affecting adults and children, regardless of their socioeconomic status. Significant progress has been made in understanding the genetic causes contributing to obesity, shedding light on a portion of cases worldwide. In young children with severe obesity however, recessive mutations, i.e., leptin or leptin receptor deficiency should be sought. Much more has been learned about the far-reaching impact of obesity on complications, including cardiovascular disease, liver and kidney dysfunction, diabetes, inflammation, hypertension, sleep, cancer, and the eye. Preventive strategies, particularly in children, are crucial for reducing obesity rates and mitigating its long-term complications. While dietary modifications and lifestyle changes remain the cornerstone of obesity prevention or treatment, recent advancements have introduced highly effective pharmacological options complementing weight-reduction surgery. Newer medications, like incretin-based therapies including glucagon-like peptide-1 agonists (GLP-1RA), have demonstrated remarkable efficacy in promoting weight loss, offering new insights into margining obesity-related conditions. Primary care providers, whether treating adults or children, play a pivotal role in preventing obesity, initiating treatment, and making onward referrals to specialists to assist in managing obesity and obesity-related complications.
KW - Complications
KW - Lifestyle
KW - Metabolic surgery
KW - Obesity
KW - Pharmacotherapy
KW - Primary care
UR - https://www.scopus.com/pages/publications/105003940628
U2 - 10.1016/j.jdiacomp.2025.109045
DO - 10.1016/j.jdiacomp.2025.109045
M3 - Review article
C2 - 40305970
AN - SCOPUS:105003940628
SN - 1056-8727
VL - 39
JO - Journal of Diabetes and its Complications
JF - Journal of Diabetes and its Complications
IS - 7
M1 - 109045
ER -